Search
Close this search box.

Rhodes, Manhard join Acadia

ARTICLE | Management Tracks

Plus: Vivodyne hires Menschik as CTO and an update from Enhanc3D

By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst

February 1, 2024 12:34 AM UTC

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) named Jennifer Rhodes as EVP, chief legal officer, and Kimberly Manhard as SVP, global strategic planning and execution. Rhodes, who will succeed EVP, General Counsel Austin Kim after a short transition period, was most recently CBO and general counsel at Angion Biomedica Corp. Manhard joins from Heron Therapeutics Inc. (NASDAQ:HRTX), where she was EVP, drug development. Kim is leaving to pursue other opportunities. 

Human organ model company Vivodyne Inc. hired Elliot Menschik as CTO and appointed him to the company’s board. Menschik was part of the founding leadership team and chief digital officer at National Resilience Inc…